Literature DB >> 9158182

Principles and guidelines for surgeons--management of symptomatic breast cancer. European Society of Surgical Oncology.

M Blichert-Toft1, M G Smola, L Cataliotti, N O'Higgins.   

Abstract

The European Society of Surgical Oncology is actively involved in the promotion of a high standard of surgical oncology throughout Europe. Such an ambition involves recognition of Centres of Excellence in the management of cancer patients throughout Europe. These centres have a multi-disciplinary system involved in the total care of patients with cancer and are concerned with the delivery of care to the highest available standards. It is accepted that not all patients with cancer can, nor should, necessarily be treated in such highly specialized centres. Yet all cancer patients should be guaranteed a high standard of care. High surgical standards can be ensured if surgeons treating cancer are trained in specialist centres and, when in independent practice, follow established guidelines or protocols of treatment. In common with many national surgical oncology societies, the European Society of Surgical Oncology is in the process of establishing good practice guidelines in the treatment of solid tumours. This document on the management of symptomatic breast cancer is the first of a series of guidelines to be proposed by ESSO. It draws heavily on excellent documents already in existence from the British Association of Surgical Oncology and from the Danish Breast Cancer Co-Operative Group. It is hoped that this document will be sufficiently clear and purposeful to be of help to the individual surgeon and yet sufficiently flexible to allow it to be adopted in the different medical systems throughout Europe.

Entities:  

Mesh:

Year:  1997        PMID: 9158182     DOI: 10.1016/s0748-7983(97)80001-7

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer. A short-term audit.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 2.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

3.  Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  Delays in the Surgical Pathway in Breast cancer Patients in Tunisia: A Descriptive Prospective Study.

Authors:  Kahlaoui Meriam; Limam Manel; Sahli Jihene; Khairi Hédi; Mtiraoui Ali; Ajmi Thouraya
Journal:  Indian J Surg Oncol       Date:  2021-12-02

5.  Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.

Authors:  G Cserni; I Amendoeira; N Apostolikas; J P Bellocq; S Bianchi; W Boecker; B Borisch; C E Connolly; T Decker; P Dervan; M Drijkoningen; I O Ellis; C W Elston; V Eusebi; D Faverly; P Heikkila; R Holland; H Kerner; J Kulka; J Jacquemier; M Lacerda; J Martinez-Penuela; C De Miguel; J L Peterse; F Rank; P Regitnig; A Reiner; A Sapino; B Sigal-Zafrani; A M Tanous; S Thorstenson; E Zozaya; G Fejes; C A Wells
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

6.  Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark.

Authors:  Elsebeth Lynge; Anna-Belle Beau; My von Euler-Chelpin; George Napolitano; Sisse Njor; Anne Helene Olsen; Walter Schwartz; Ilse Vejborg
Journal:  Breast Cancer Res Treat       Date:  2020-08-30       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.